Meet the Formulator

From Big Pharma
to Pet Wellness

Shan Kanthar spent 30 years making medicines people trust with their lives - at AstraZeneca, Parnell, Virbac, and Auscann. When he looked at the pet supplement industry, he found it unacceptable. So he built something better.

AstraZeneca · 14 yrsParnell PharmaceuticalsVirbacAuscannMS Medicinal ChemistryB.Pharm (CSU)
SK
Shan Kanthar
Founder & Chief Scientist - BDS Animal Health
30+
Years pharmaceutical experience
14
Years at AstraZeneca
5
Science-backed formulas
100%
Every batch independently tested
The Story

Built by someone who was
angry about the industry

After 14 years formulating sterile injectables and asthma inhalers at AstraZeneca's North Ryde facility, Shan Kanthar looked at the Australian pet supplement industry and found it unacceptable.

Not marginally below standard. Unacceptable. Ingredients he would never have been permitted to use in human medicine were standard in pet supplements. Supply chains that would fail a pharmaceutical audit were commonplace. Batch testing — a non-negotiable in every pharma facility he'd worked in — was largely absent.

"

I have spent my entire career making medicines that people trust with their lives. I held pet nutrition to the same standard. The industry wasn't doing that. So I built a company that does.

- Shan Kanthar, Founder & Chief Scientist, BDS Animal Health

The result is BDS Animal Health — a state-of-the-art manufacturing facility in Clandulla, NSW built to pharmaceutical standards. Every product formulated in-house. Every batch independently tested. Every ingredient traceable to source.

SK
Shan Kanthar
Founder & Chief Scientist - BDS Animal Health
AstraZenecaProcess Manager · 14 years · Pulmicort
Parnell PharmaceuticalsManufacturing Director · Zydax & Glyde
VirbacIndustrial Development Manager · Suprelorin
AuscannHead of Manufacturing & QA · SEDDS technology
BDS Animal HealthDirector of Manufacturing & Chief Scientist · 2024–Present
Academic Foundation

The education
behind the formulas

Three postgraduate qualifications across medicinal chemistry, drug development, and pharmacy — nearly two decades of academic training that underpins every BDS formulation decision.

1996 – 1998
MS Medicinal Chemistry
University of Wollongong
Specialisation: Anti-cancer antibiotics & drug design
2001 – 2004
PGD Drug Development
UNSW - Faculty of Medicine
Concept-to-market pharmaceutical product lifecycle
2009 – 2013
Bachelor of Pharmacy
Charles Sturt University
Professional pharmaceutical registration (AHPRA)
Career Timeline

30 years of expertise
behind every formula

Each career chapter shaped a specific BDS product. This isn't a generic supplement company — it's a pharmaceutical career applied to pet health.

Tap any role to expand

AstraZeneca - North Ryde, Sydney · 14 years
Process Manager
Key product: Pulmicort - one of the world's most prescribed asthma medications
+

Formulation and process validation of sterile injectables and nebulised corticosteroid treatments at AstraZeneca's Australian facility. Fourteen years operating to GMP — the highest international pharmaceutical standard. Every batch tested. Every ingredient traced. That discipline became the non-negotiable foundation of BDS Animal Health.

Sterile injectablesCorticosteroid formulationGMP manufacturingProcess validationAseptic processing
Parnell Pharmaceuticals
Manufacturing Director
Key products: Zydax & Glyde - veterinary joint therapy industry standards
+

Sterile hormone manufacturing for veterinary use. Led development of injectable anti-arthritic formulations for dogs — Glyde and Zydax — which became the veterinary industry standard. This is where Shan's pharmaceutical expertise first directly intersected with animal health.

Direct BDS Connection: Osteo Connect applies the same pharmaceutical DNA as Glyde — glucosamine HCl, chondroitin sulphate, and green-lipped mussel at therapeutic concentrations. Formulated by the same hands that built the category standard.
Virbac - World's Leading Animal Pharmaceutical Company
Industrial Development Manager
Key product: Suprelorin - transdermal contraceptive implant for dogs
+

Advanced drug delivery systems including long-acting transdermal implant technology for veterinary use. Virbac is the global benchmark in animal pharmaceuticals — this role deepened Shan's mastery of bioavailability engineering and precision drug delivery, disciplines that directly inform how BDS formulates for maximum absorption.

Transdermal deliveryControlled releaseVeterinary formulationBioavailability engineering
Auscann - Drug Delivery Innovation
Head of Manufacturing & QA
Breakthrough: Australia's first solid powdered cannabinoid capsule using SEDDS nano-technology
+

Solved a core pharmaceutical challenge: delivering oil-based therapeutic compounds in stable, highly bioavailable solid form. Developed Australia's first solid powdered cannabinoid capsule using self-emulsifying drug delivery system (SEDDS) — nano-formulation technology that converts oils into dry powder the body absorbs far more efficiently.

Direct BDS Connection: Luminous uses this exact SEDDS nano-formulation technology to deliver Omega-3 and Omega-6 fatty acids as a dry, palatable, highly bioavailable powder — solving the long-standing problem of dogs refusing or poorly absorbing fish oils.
BDS Manufacturing Pty Ltd - Clandulla, NSW · 2024–Present
Director of Manufacturing & Chief Scientist
30 years of pharmaceutical expertise, now applied to Australian pet nutrition
+

BDS Animal Health operates a state-of-the-art facility in Clandulla, NSW built to pharmaceutical standards. Every product formulated in-house by Shan. Pharmaceutical-grade ingredients — USP-NF standard. All batches independently tested by TGA-approved external laboratories before shipping. Certificate of Analysis available on request.

Nano formulationHuman + Pet nutritionQuality AssuranceTGA facility operationsR&D
In His Own Words
"

At AstraZeneca, we didn't batch-test some products — we tested every batch. We didn't trace some ingredients — we traced every ingredient. That rigor saved lives in human medicine. Our pets deserve the same precision. That's why I built BDS with full pharmaceutical manufacturing standards, not 'pet supplement' shortcuts.

Shan Kanthar
Founder & Chief Scientist, BDS Animal Health
Why It Matters

Why pharmaceutical standards matter for pet supplements

The Australian pet supplement market is largely unregulated. Ingredient quality varies enormously between brands. Independent batch testing is rare. Supply chains are frequently opaque. Products are built by marketing teams, not scientists.

In human pharmaceuticals, none of this would be acceptable. Regulatory bodies enforce ingredient grades, manufacturing conditions, batch testing, and full traceability. That's why medicines work.

Shan built BDS to apply the same actual standard — verified by third-party laboratories, manufactured in a certified facility, formulated by a qualified scientist with 30 years of experience. Not the same marketing language. The same actual standard.

Same Standards, Different Patient

Pharmaceutical quality —
verified, not just claimed

Unlike brands that use "pharmaceutical-grade" as a marketing phrase, BDS can verify every claim with third-party evidence and a facility you can visit.

Standard AstraZeneca (Human) BDS Animal Health Typical Pet Brands
Ingredient Grade ✓ USP-NF Pharmaceutical ✓ USP-NF Pharmaceutical ✗ Feed-grade or food-grade
Batch Testing ✓ 100% with Certificate of Analysis ✓ 100% — COA available on request ✗ Spot-checking or untested
Sterile Processing ✓ Full aseptic protocols ✓ Full aseptic protocols ✗ Rarely applied
Ingredient Traceability ✓ Full chain of custody ✓ Full chain of custody ✗ Opaque supply chains
Expert Oversight ✓ PhD/PharmD scientists ✓ 30+ year pharmaceutical scientist ✗ Marketing teams or contractors